Noxopharm (ASX:NOX) Short-Term Capital Lease Obligation : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Short-Term Capital Lease Obligation?

Noxopharm's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Noxopharm's annual Short-Term Capital Lease Obligation declined from Jun. 2021 (A$0.23 Mil) to Jun. 2022 (A$0.16 Mil) and declined from Jun. 2022 (A$0.16 Mil) to Jun. 2023 (A$0.00 Mil).

Noxopharm Short-Term Capital Lease Obligation Historical Data

The historical data trend for Noxopharm's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm Short-Term Capital Lease Obligation Chart

Noxopharm Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.25

0.23

0.16

Noxopharm Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial										-	0.16	-	-	-

Noxopharm Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Noxopharm Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Noxopharm's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Noxopharm (ASX:NOX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

NOXOF:USA

Address

60 Linksley Ave, Glenhaven, NSW, AUS, 2156

Website

https://www.noxopharm.com

Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines